Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study

[31] Idupulapati M(2013)Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications Neuron 77 696-711

[32] Harris JB(2009)Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition Clin Radiol 64 12-21

[33] Crisostomo RA(2006)Fragile X syndrome: a pilot proton magnetic resonance spectroscopy study in premutation carriers Trends Pharmacol Sci 27 141-148

[34] Larsen BP(2012)Clinical involvement and protein expression in individuals with the FMR1 premutation J Neurodev Disord 4 23-152

[35] Kooy F(2000)In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism Am J Med Genet 91 144-205

[36] Willems PJ(2011)Psychiatric and autistic comorbidity in fragile X syndrome across ages Brain Res 1380 198-948

[37] Cras P(2011)GABA system dysfunction in autism and related disorders: from synapse to symptoms J Child Neurol 26 940-2055

[38] Kozlowski PB(2012)Common circuit defect of excitatory-inhibitory balance in mouse models of autism Neurosci Biobehav Rev 36 2044-181

[39] Swain RA(2009)Fragile X: leading the way for targeted treatments in autism J Neurodev Disord 1 172-274

[40] Weiler IJ(2010)Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging Neurotherapeutics 7 264-85

[31] Idupulapati M(2013)Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications Neuron 77 696-711

[32] Harris JB(2009)Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition Clin Radiol 64 12-21

[33] Crisostomo RA(2006)Fragile X syndrome: a pilot proton magnetic resonance spectroscopy study in premutation carriers Trends Pharmacol Sci 27 141-148

[34] Larsen BP(2012)Clinical involvement and protein expression in individuals with the FMR1 premutation J Neurodev Disord 4 23-152

[35] Kooy F(2000)In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism Am J Med Genet 91 144-205

[36] Willems PJ(2011)Psychiatric and autistic comorbidity in fragile X syndrome across ages Brain Res 1380 198-948

[37] Cras P(2011)GABA system dysfunction in autism and related disorders: from synapse to symptoms J Child Neurol 26 940-2055

[38] Kozlowski PB(2012)Common circuit defect of excitatory-inhibitory balance in mouse models of autism Neurosci Biobehav Rev 36 2044-181

[39] Swain RA(2009)Fragile X: leading the way for targeted treatments in autism J Neurodev Disord 1 172-274

[40] Weiler IJ(2010)Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging Neurotherapeutics 7 264-85